To this end, it seems as if direct blockade of more than one IL-17 homologue potentially increases efficacy, but also characteristic safety signals (candida infections), while modulating the inflammatory milieu via interference with signal transduction may result in a lower clinical efficacy compared to direct blockade of IL-17. This evidence concerns the gene IL17A and candidiasis.